188 related articles for article (PubMed ID: 26220827)
1. Clinical Significance of EphB4 and EphB6 Expression in Human Malignant and Benign Thyroid Lesions.
Giaginis C; Alexandrou P; Poulaki E; Delladetsima I; Troungos C; Patsouris E; Theocharis S
Pathol Oncol Res; 2016 Apr; 22(2):269-75. PubMed ID: 26220827
[TBL] [Abstract][Full Text] [Related]
2. Clinical Significance of Hu-Antigen Receptor (HuR) and Cyclooxygenase-2 (COX-2) Expression in Human Malignant and Benign Thyroid Lesions.
Giaginis C; Alexandrou P; Delladetsima I; Karavokyros I; Danas E; Giagini A; Patsouris E; Theocharis S
Pathol Oncol Res; 2016 Jan; 22(1):189-96. PubMed ID: 26498465
[TBL] [Abstract][Full Text] [Related]
3. Clinical Significance of Cannabinoid Receptors CB1 and CB2 Expression in Human Malignant and Benign Thyroid Lesions.
Lakiotaki E; Giaginis C; Tolia M; Alexandrou P; Delladetsima I; Giannopoulou I; Kyrgias G; Patsouris E; Theocharis S
Biomed Res Int; 2015; 2015():839403. PubMed ID: 26539529
[TBL] [Abstract][Full Text] [Related]
4. Expression of ki67 in papillary thyroid microcarcinoma and its clinical significance.
Zhou Y; Jiang HG; Lu N; Lu BH; Chen ZH
Asian Pac J Cancer Prev; 2015; 16(4):1605-8. PubMed ID: 25743839
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of EphB4, EphrinB2, and epidermal growth factor receptor in papillary thyroid carcinoma: A pilot study.
Sharma GK; Dhillon VK; Masood R; Maceri DR
Head Neck; 2015 Jul; 37(7):964-9. PubMed ID: 24634162
[TBL] [Abstract][Full Text] [Related]
6. Eph-A2 and Eph-A4 expression in human benign and malignant thyroid lesions: an immunohistochemical study.
Karidis NP; Giaginis C; Tsourouflis G; Alexandrou P; Delladetsima I; Theocharis S
Med Sci Monit; 2011 Sep; 17(9):BR257-65. PubMed ID: 21873938
[TBL] [Abstract][Full Text] [Related]
7. [Usefulness of CK19, HBME-1 and galectin-3 expressions in differential diagnosis of thyroid papillary microcarcinoma from benign lesions].
Tong J; Wang Y; Da JP
Zhonghua Zhong Liu Za Zhi; 2011 Aug; 33(8):599-604. PubMed ID: 22325220
[TBL] [Abstract][Full Text] [Related]
8. Oncoproteins and tumor progression in papillary thyroid carcinoma: presence of epidermal growth factor receptor, c-erbB-2 protein, estrogen receptor related protein, p21-ras protein, and proliferation indicators in relation to tumor recurrences and patient survival.
Akslen LA; Varhaug JE
Cancer; 1995 Nov; 76(9):1643-54. PubMed ID: 8635070
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of S100C in thyroid lesions.
Torres-Cabala C; Panizo-Santos A; Krutzsch HC; Barazi H; Namba M; Sakaguchi M; Roberts DD; Merino MJ
Int J Surg Pathol; 2004 Apr; 12(2):107-15. PubMed ID: 15173915
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of farnesoid X receptor expression in thyroid neoplasia.
Giaginis C; Tsoukalas N; Alexandrou P; Tsourouflis G; Dana E; Delladetsima I; Patsouris E; Theocharis S
Future Oncol; 2017 Aug; 13(20):1785-1792. PubMed ID: 28762281
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of histone deacetylase (HDAC)-1, HDAC-2, HDAC-4, and HDAC-6 expression in human malignant and benign thyroid lesions.
Giaginis C; Alexandrou P; Delladetsima I; Giannopoulou I; Patsouris E; Theocharis S
Tumour Biol; 2014 Jan; 35(1):61-71. PubMed ID: 23873102
[TBL] [Abstract][Full Text] [Related]
12. Uncommon BRAF mutations in the follicular variant of thyroid papillary carcinoma: New insights.
Rossi ED; Martini M; Bizzarro T; Capodimonti S; Cenci T; Lombardi CP; Pontecorvi A; Fadda G; Larocca LM
Cancer Cytopathol; 2015 Oct; 123(10):593-602. PubMed ID: 26230187
[TBL] [Abstract][Full Text] [Related]
13. Up-regulation of nuclear receptor coactivator amplified in breast cancer-1 in papillary thyroid carcinoma correlates with lymph node metastasis.
Liu MY; Guo HP; Hong CQ; Peng HW; Yang XH; Zhang H
Clin Transl Oncol; 2013 Nov; 15(11):947-52. PubMed ID: 23606350
[TBL] [Abstract][Full Text] [Related]
14. Differential protein expression and oncogenic gene network link tyrosine kinase ephrin B4 receptor to aggressive gastric and gastroesophageal junction cancers.
Liersch-Löhn B; Slavova N; Buhr HJ; Bennani-Baiti IM
Int J Cancer; 2016 Mar; 138(5):1220-31. PubMed ID: 26414866
[TBL] [Abstract][Full Text] [Related]
15. Erythropoietin-Producing Hepatocellular A1 is an Independent Prognostic Factor for Gastric Cancer.
Nakagawa M; Inokuchi M; Takagi Y; Kato K; Sugita H; Otsuki S; Kojima K; Uetake H; Sugihara K
Ann Surg Oncol; 2015 Jul; 22(7):2329-35. PubMed ID: 25391265
[TBL] [Abstract][Full Text] [Related]
16. The Wnt/β-catenin pathway drives increased cyclin D1 levels in lymph node metastasis in papillary thyroid cancer.
Zhang J; Gill AJ; Issacs JD; Atmore B; Johns A; Delbridge LW; Lai R; McMullen TP
Hum Pathol; 2012 Jul; 43(7):1044-50. PubMed ID: 22204713
[TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factors and angiopoietins in presentations and prognosis of papillary thyroid carcinoma.
Hsueh C; Lin JD; Wu IC; Chao TC; Yu JS; Liou MJ; Yeh CJ
J Surg Oncol; 2011 Apr; 103(5):395-9. PubMed ID: 21400522
[TBL] [Abstract][Full Text] [Related]
18. Reduced EphB6 protein in gastric carcinoma and associated lymph nodes suggests EphB6 as a gastric tumor and metastasis inhibitor.
Liu J; Xu B; Xu G; Zhang X; Yang X; Wang J
Cancer Biomark; 2017 Jul; 19(3):241-248. PubMed ID: 28453458
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological Features and Prognosis of Papillary Thyroid Microcarcinoma for Surgery and Relationships with the BRAFV600E Mutational Status and Expression of Angiogenic Factors.
Shi C; Guo Y; Lv Y; Nanding A; Shi T; Qin H; He J
PLoS One; 2016; 11(12):e0167414. PubMed ID: 27936049
[TBL] [Abstract][Full Text] [Related]
20. Receptor-binding cancer antigen expressed on SiSo cells (RCAS1) expression in human benign and malignant thyroid lesions.
Giaginis C; Demetriou N; Alexandrou P; Stolakis V; Delladetsima I; Klijanienko J; Griniatsos I; Theocharis S
Med Sci Monit; 2012 Apr; 18(4):BR123-9. PubMed ID: 22460085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
